ONO‐7684 a novel oral FXIa inhibitor: Safety, tolerability, pharmacokinetics and pharmacodynamics in a first‐in‐human study

por Beale, Dominic, Dennison, Jeremy, Boyce, Malcolm, Mazzo, Francesca, Honda, Naoki, Smith, Paul, Bruce, Mark
Publicado 2021